March 8, 2017
This media is currently available only to those that pre-purchased it during the conference registration process or at the conference registration desk. Media will be available for purchase to all CRRTonline.com subscribers at a later date.
Emails were sent to purchasers on April 3 with instructions and coupon codes that enable access to the media.
Please Note: Some lectures presented at the conference may not be available because of copyright issues.
Plenary 1 MINI-SYMPOSIA – Organ Dysfunction in the Critically Ill Patient: Emerging Concepts
- Opening Remarks – Ravindra L Mehta, MD
- What’s New in ARDS? – Kathleen Liu, MD
- AKI in Trauma Patients – Jacques Duranteau, MD
- The Critically Ill Burn Patient – Matthieu LeGrand, MD
- Personalized Medicine in Sepsis: Inhibition and Stimulation of the Immune System – Peter Pickkers, MD
- Shared Decision Making in the ICU – Judy E. Davidson, DNP, RN
- Panel Discussion – Moderator: John Kellum, MD
Plenary 2 MINI-SYMPOSIA – Acute Kidney Injury (AKI): Pathophysiology
- Preeclampsia: Pathophysiology and Novel Therapeutic Options – Ravi Thadhani, MD
- Immunoregulatory Role of Tissue Microenvironment in Kidney Injury – Mark Okusa, MD
- AKI in Kidney Transplantation – Hamid Rabb, MD
- Renal Venous Congestion: The Unrecognized Culprit? – Matthieu LeGrand, MD
- Does Urine Output Monitoring Improve Outcome? – John Kellum, MD
- New Advances in the Treatment of Severe Sepsis and Septic Shock – Jean-Louis Vincent, MD
March 9, 2017
Plenary 3 MINI-SYMPOSIA – Challenges in ICU Management
- The 10 Elements that Can Improve Outcomes in Sepsis – Jean Louis Vincent, MD
- Lactate: Good or Bad Guy? – Lui Forni, MD
- Neonatal AKI – Data from the International AWAKEN Study – David Askenazi, MD
- We Should Measure Fluid Deficiency Not Fluid Responsiveness – Andrew D. Shaw, MB
- Evaluating Muscle Mass Using Markers of Kidney Function: Sarcopenia Index – Kianoush Kashani, MD
- AKI in the Patient with Cancer – Mitch H. Rosner, MD
- SPECIAL LECTURE – Translating to Management Award Clinical Applications of Biomarkers in AKI: Lessons from the TRIBE-AKI Studies – Chirag Parikh, MD, PhD
- Top Abstract Awards
Plenary 4 MINI SYMPOSIA – Novel Strategies in AKI Management
- Acute Interstitial Nephritis: An Update – Chirag Parikh, MD, PhD
- Real Time Measurement of GFR Using an Optical Transdermal – Fluorescence System – Richard Solomon, MD
- Current and Potential Role of Point-of-care Ultrasound in Acute Kidney Injury – Jacques Duranteau, MD
- AWARE – Operationalizing The Renal Angina Index and Biomarkers to Predict Severe AKI – Stuart Goldstein, MD
- Biomarkers of Drug-induced Kidney Injury: Findings of the SAFE-T Consortium – Patrick Murray, MD
Plenary 5 MINI SYMPOSIA – Challenges and Controversies in Renal Support and CRRT
- Blood Purification for Sepsis Patients Based on the Current Pathophysiology of Sepsis – Patrick Honoré, MD
- Nutrient Deficiency in AKI and Losses During CRRT – Marlies Ostermann, MD
- Serum Creatinine Variability: A Renal Vital Sign? – Lakhmir Chawla, MD
- SPECIAL LECTURE – Precision CRRT: Results from ADQI 17 – Claudio Ronco, MD
- Viewpoints: Timing of RRT in AKI
We Know When to Start: Alex Zarbock, MD
We Are Still Trying to Find Out: Ron Wald, MD
We Are a Long Ways Off: Glenn Chertow, MD
March 10, 2017
Plenary 6 MINI SYMPOSIA – Global Burden of AKI
- Population Based Study of AKI Epidemiology – Kianoush Kashani, MD
- The DoRemi Trial – Claudio Ronco, MD
- Optimal Circumstances and Utilization of RRT in Older Critically Ill Patients Including Presenting the Results of the OPTIMAL-AKI Study – Azra Bihorac, MD
- AKI in the ICU: The Intensive Care Over Nations (ICON) Audit – Peter Pickkers, MD
- Pattern and Outcome of AKI in Tertiary care Hospital in India – Sanjay Agarwal, MD
- Education and Training to Raise Awareness of AKI in the Community – Andrew Lewington, MD
- The ISN 0by25 AKI Pilot Study: What Have We Learnt? – Ravindra Mehta, MD
- Community Acquired AKI in Resource Constrained Settings: Risk Assessment and Management – Etienne Macedo, MD
- SPECIAL LECTURE – Management of AKI in the Developing World: Highlights from ADQI 18 – Raj Chakaravarthi, MD
Plenary 7 MINI SYMPOSIA – Emerging Strategies in AKI and Extracorporeal Support
- Drug Induced Nephrotoxicity: Findings from the DIRECT Study – Linda Awdishu, MD
- Update from Ongoing and Late Breaking Trials
Alkaline Phosphatase for Septic AKI – Peter Pickkers, MD
STAART AKI Trial Update – Kathleen Liu, MD
Prevention of Cardiac Surgery Associated AKI: The Prev AKI Trial – Alex Zarbock, MD - Critical Care Nephrology: Literature Review – Noel Gibney, MB
- Closing Remarks – Ravindra L. Mehta, MD
Breakfast Symposia Sessions (4)
A. Fluids and Vasopressor Management in the ICU
B. Management of AKI in Sepsis: Are We Ready?
C. Innovations in Caring for Patients with Hyponatremia
D. Measuring Outcomes in AKI and CRRT: Which Benchmarks Should We Use?
Lunch Symposia Sessions (8)
W1. Measuring Renal Function: Which Biomarkers?
W2. Fluid Management of the Critically Ill Patient: Crystalloids, Colloids and Blood Products
W3. Extracorporeal Support for Multiorgan Failure: Emerging Strategies
W4. Establishing and Maintaining Core Competencies for Nurses for CRRT
T1. Biomarker Guided Management of AKI: Strategies for Improving Care
T2. Hydration and Kidney Health
T3. Imaging Modalities for Patients with AKI and CKD
T4. Therapeutic Challenges in AKI and CKD: Managing Acid Base and Electrolyte Problems